# US Oncology Research clinical trials: 29 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with US Oncology Research as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by US Oncology Research: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/us-oncology-research

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 2, 2023 | NCT05885698 | MYLUNG Consortium Part 3: Observational Study | US Oncology Research | Observational | Recruiting | Carcinoma, Non-Small-Cell Lung | 7,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05885698) |
| December 9, 2022 | NCT05644808 | MYLUNG Consortium Study Protocol 2 | US Oncology Research | Observational | Active not recruiting | Carcinoma, Non-Small-Cell Lung | 1,002 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05644808) |
| March 4, 2021 | NCT04782687 | Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma | US Oncology Research | Phase 2 | Active not recruiting | Multiple Myeloma, Myeloma Multiple, Kahler Disease, Myeloma, Plasma Cell, Myeloma-Multiple, Myelomatosis, Plasma Cell... | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04782687) |
| December 20, 2017 | NCT03379428 | Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer | US Oncology Research | Phase 1/2 | Active not recruiting | Breast Neoplasms, Malignant Neoplasm of Breast | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03379428) |
| April 24, 2015 | NCT02425683 | Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX | US Oncology Research | Phase 2 | Terminated | Colorectal Neoplasms, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02425683) |
| August 29, 2014 | NCT02229149 | Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer | US Oncology Research | Phase 2 | Terminated | Breast Neoplasms, Malignant Tumor of the Breast | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02229149) |
| August 29, 2014 | NCT02229136 | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | US Oncology Research | Phase 2 | Completed | Stomatitis, Oral Mucositis, Neoplasm of the Breast, Malignant Tumor of Breast | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02229136) |
| July 11, 2014 | NCT02187991 | Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer | US Oncology Research | Phase 2 | Completed | Breast Cancer, Breast Carcinoma, Breast Tumors, Malignant Neoplasm of Breast | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02187991) |
| December 4, 2013 | NCT02000882 | STAR Cape+BKM120 MBC With Brain Met | US Oncology Research | Phase 2 | Completed | Brain Metastases, Breast Cancer, Metastatic Breast Cancer | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02000882) |
| September 4, 2013 | NCT01934634 | Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer | US Oncology Research | Phase 1 | Unknown | Metastatic Pancreatic Cancer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01934634) |
| July 26, 2013 | NCT01909362 | Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC) | US Oncology Research | Observational | Completed | Colorectal Neoplasms, Advanced Metastatic Colorectal Cancer | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01909362) |
| December 6, 2012 | NCT01744197 | Synera Venipuncture Pain | US Oncology Research | Phase 2 | Completed | Pain, Phlebotomy, Palliative Care | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01744197) |
| April 27, 2010 | NCT01111175 | Triple Negative Breast Cancer Biomarker Study | US Oncology Research | Observational | Completed | Metastatic Breast Cancer, Triple Negative Breast Cancer | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01111175) |
| February 24, 2010 | NCT01075100 | Ixabepilone + Carboplatin Metastatic Breast Cancer | US Oncology Research | Phase 2 | Completed | Metastatic Breast Cancer | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01075100) |
| March 19, 2009 | NCT00864721 | Sunitinib Non Small Cell Lung Cancer Patients Over 70 | US Oncology Research | Phase 2 | Completed | Non Small Cell Lung Cancer | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00864721) |
| January 13, 2009 | NCT00821327 | Gemzar, Cisp, Sunitinib Urothelial Ca | US Oncology Research | Phase 2 | Completed | Urothelial Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00821327) |
| April 18, 2008 | NCT00661492 | Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) | US Oncology Research | Phase 2 | Completed | Androgen-independent Prostate Cancer | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00661492) |
| April 10, 2008 | NCT00656084 | Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell | US Oncology Research | Phase 2 | Completed | Relapsed or Refractory Mantle Cell Lymphoma (MCL) | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00656084) |
| January 23, 2008 | NCT00599313 | Phase II Sunitinib Prog Met AIPC | US Oncology Research | Phase 2 | Completed | Metastatic Prostate Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00599313) |
| September 10, 2007 | NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | US Oncology Research | Phase 2 | Completed | Rectal Cancer | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00527111) |
| August 17, 2007 | NCT00517829 | Docetaxel+Oxali+/-Cetux Met Gastric/GEJ | US Oncology Research | Phase 2 | Completed | Gastric Cancer Adenocarcinoma Metastatic | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00517829) |
| June 28, 2007 | NCT00493870 | TAC Versus TC for Adjuvant Breast Cancer | US Oncology Research | Phase 3 | Completed | Breast Cancer | 1,961 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00493870) |
| June 28, 2007 | NCT00493649 | Adj TC + Herceptin Early Stage Breast Cancer | US Oncology Research | Phase 2 | Completed | Breast Cancer | 493 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00493649) |
| October 6, 2006 | NCT00384839 | Vidaza to Restore Hormone Thx Prostate | US Oncology Research | Phase 2 | Completed | Prostate Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00384839) |
| March 15, 2006 | NCT00303108 | Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer | US Oncology Research | Phase 2 | Completed | Metastatic Breast Cancer | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00303108) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 20 |
| Phase 3 | 3 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Active not recruiting | 4 |
| Terminated | 3 |
| Unknown | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 11 |
| Colorectal Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Rectal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Recurrence | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Pain | 1 |
| Agnosia | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Colonic Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Stomatitis | 1 |
| Oral Ulcer | 1 |
| Multiple Myeloma | 1 |
| Neoplasms, Plasma Cell | 1 |
| Neoplasm Metastasis | 1 |
| Lymphoma, Non-Hodgkin | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
- [Family practice clinics in the United States](https://specstream.ai/data/businesses/family-practice-clinics/united-states)
- [Nigerian restaurants in the United States](https://specstream.ai/data/businesses/nigerian-restaurants/united-states)
- [Translation and interpreting companies in the United States](https://specstream.ai/data/businesses/translation-and-interpreting-companies/united-states)
- [Child care centers in the United States](https://specstream.ai/data/businesses/child-care-centers/united-states)
- [HVAC contractors in the United States](https://specstream.ai/data/businesses/hvac-contractors/united-states)
